Cardiomyopathic etiology and SERCA2a reverse remodeling during mechanical support of the failing human heart

Anesthesia and Analgesia

Volumn 102, Issue 1, 2006, Pages 32-37

  Heerdt, Paul M ^a,c   Klotz, Stefan ^b   Burkhoff, Daniel ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Box 50 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; MESSENGER RNA; PROTEIN SERCA2A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM TRANSPORT; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; FORCE FREQUENCY RELATIONSHIP; GENE EXPRESSION REGULATION; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION TEST; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; SARCOPLASMIC RETICULUM; TRANSCRIPTION REGULATION;

EID: 29844453912     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000183642.09435.ad     Document Type: Article

References (25)

1. Goldstein DJ, Mullis SL, Delphin ES, et al. Noncardiac surgery in long-term implantable left ventricular assist-device recipients. Ann Surg 1995;222:203-7.
2. Mets B. Anesthesia for left ventricular assist device placement. J Cardiothorac Vasc Anesth 2000;14:316-26.
3. Levin HR, Oz MC, Chen JM, et al. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995;91:2717-20.
4. Altemose GT, Gritsus V, Jeevanandam V, et al. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant 1997;16:765-73.
5. Heerdt PM, Holmes JW, Cai B, et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 2000;102:2713-9.
6. Dipla K, Mattiello JA, Jeevanandam V, et al. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 1998;97:2316-22.
7. Barbone A, Holmes JW, Heerdt PM, et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation 2001;104:670-5.
8. Zhang J, Narula J. Molecular biology of myocardial recovery. Surg Clin North Am 2004:84:223-42.
9. Arai M, Alpert NR, MacLennan DH, et al. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 1993;72:463-9.
10. Munch G, Bolck B, Brixius K, et al. SERCA2a activity correlates with the force-frequency relationship in human myocardium. Am J Physiol Heart Circ Physiol 2000;278:H1924-32.
11. Heerdt PM, Schlame M, Burkhoff D, Blanck TJJB. Disease-specific remodeling of mitochondrial membranes in failing human hearts following unloading by a left ventricular assist device. Ann Thorac Surg 2002;73:1216-21.
12. Chen Y, Park S, Li Y, et al. Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol Genomics 2003;14:251-60.
13. Entwistle JW 3rd. Long-term mechanical ventricular assistance toward myocardial recovery. Cardiol Clin 2003;21:75-82.
14. Hon JK, Yacoub MH. Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg 2003;75:536-41.
15. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Pharmacol Rev 1999;79:215-62.
16. Estrada-Quintero T, Uretsky BF, Murali S, et al. Neurohormonal activation and exercise function in patients with severe heart failure and patients with left ventricular assist system. Chest 1995;107:1499-503.
17. Heerdt PM, Burkhoff D. Reverse molecular remodeling of the LVAD-supported heart. In: Singal PK, Dixon IMC, Kirshenbaum LA, Dhalla NS, eds. Cardiovascular remodeling and failure. Boston: Kluwer Academic Publishers, 2003:19-36.
18. Madigan JD, Barbone A, Choudhri AF, et al. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg 2001;121:902-8.
19. Hollams EM, Giles KM, Thomson AM, Leedman PJ. MRNA stability and the control of gene expression: implications for human disease. Neurochem Res 2002;27:957-80.
20. Weyrich AS, Lindemann S, Tolley ND, et al. Change in protein phenotype without a nucleus: translational control in platelets. Semin Thromb Hemost 2004;30:491-8.
21. Lakatta EG. Myocardial adaptations in advanced age. Basic Res Cardiol 1993;88:125-33.
22. Dash R, Frank KF, Carr AN, et al. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. J Mol Cell Cardiol 2001;33:1345-53.
23. Weber KT. Cardioreparation in hypertensive heart disease. Hypertension 2001;38:588-91.
24. Sabbah HN. The cellular and physiologic effects of beta blockers in heart failure. Cardiology 1999;22:V16-20.
25. del Monte F, Harding SE, Schmidt U, et al. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 1999;100:2308-11.